Skip to main content
Clinical Trials/NCT02113475
NCT02113475UnknownNot Applicable

A Patient Outcome Study After Pharmacomechanical Catheter-directed Thrombolysis and Standard Treatment for Venous Thrombosis

Heart and Vascular Outcomes Research Institute1 site in 1 country1,800 target enrollmentStarted: April 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,800
Locations
1
Primary Endpoint
Quality of Life,

Study Overview

Brief Summary

Deep Venous Thrombosis affects more than 350,000 individuals each year in the U.S.The Registry will track patient outcome and quality of life over 60 months for treatment with anticoagulation and elastic compression stockings and catheter-directed thrombolysis (CDT) in accordance with current treatment guidelines .

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
16 Years to 75 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Data obtained in line with good clinical practice, applicable laws and regulation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Quality of Life,

Time Frame: 60 months

Secondary Outcomes

  • Rate of Post-Thrombotic Syndrome(60 Months)

Investigators

Sponsor
Heart and Vascular Outcomes Research Institute
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials